Paper978394
Pharmacokinetics of isoniazid and some metabolites in man.
Boxenbaum HG and 1 other. J Pharmacokinet Biopharm, 1976. Cited by 42 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacokinetics of isoniazid and some metabolites in man. Papers, record 978394. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/978394
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Isoniazid | Major topic |
| Adult | |
| Humans | |
| Kinetics | |
| Male |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,851,320 | Determination of isoniazid and metabolites in biological fluids. | J Pharm Sci | 1974 | https://conductscience.org/library/papers/4851320 | PubMed |
| 3 | 5,652,110 | Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. | J Pharm Sci | 1968 | https://conductscience.org/library/papers/5652110 | PubMed |
| 4 | 14,035,027 | Control of urine pH and its effect on sulfaethidole excretion in humans. | J Pharm Sci | 1962 | https://conductscience.org/library/papers/14035027 | PubMed |
| 5 | 236,372 | Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems II: comparative pharmacokinetics in dogs. | J Pharm Sci | 1975 | https://conductscience.org/library/papers/236372 | PubMed |
| 6 | 950,592 | Pharmacokinetics of isoniazid metabolism in man. | J Pharmacokinet Biopharm | 1976 | https://conductscience.org/library/papers/950592 | PubMed |
| 7 | 4,452,938 | The influence of bacterial gut hydrolysis on the fate of orally administered isonicotinuric acid in man. | J Pharmacokinet Biopharm | 1974 | https://conductscience.org/library/papers/4452938 | PubMed |
| 8 | 5,416,180 | Two-compartment model for a drug and its metabolite: application to acetylsalicylic acid pharmacokinetics. | J Pharm Sci | 1970 | https://conductscience.org/library/papers/5416180 | PubMed |
| 9 | 6,029,065 | Fluorometric determination of isonicotinic acid hydrazide in serum. | J Lab Clin Med | 1967 | https://conductscience.org/library/papers/6029065 | PubMed |
| 11 | 5,855,885 | Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. | J Pharmacol Exp Ther | 1965 | https://conductscience.org/library/papers/5855885 | PubMed |
| 12 | 4,556,778 | Isoniazid and psuedocholinesterase polymorphisms. | Fed Proc | 1972 | https://conductscience.org/library/papers/4556778 | PubMed |
| 13 | 5,014,309 | General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics. | J Pharm Sci | 1972 | https://conductscience.org/library/papers/5014309 | PubMed |
| 14 | 5,263,687 | Genetic variations in the acetylation of isoniazid and other drugs. | Ann N Y Acad Sci | 1968 | https://conductscience.org/library/papers/5263687 | PubMed |
| 15 | 1,149,365 | Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. | Clin Pharmacol Ther | 1975 | https://conductscience.org/library/papers/1149365 | PubMed |
| 16 | 4,797,185 | Intrasubject variation in elimination half-lives of drugs which are appreciably metabolized. | J Pharmacokinet Biopharm | 1973 | https://conductscience.org/library/papers/4797185 | PubMed |
| 17 | 5,128,938 | Problems associated with analysis of pharmacokinetic models. | J Pharm Sci | 1971 | https://conductscience.org/library/papers/5128938 | PubMed |
| 18 | 5,851,956 | Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid. | J Clin Invest | 1965 | https://conductscience.org/library/papers/5851956 | PubMed |
| 19 | 14,426,447 | Kinetics of sulfisoxazole acetylation and excretion in humans. | J Pharmacol Exp Ther | 1960 | https://conductscience.org/library/papers/14426447 | PubMed |
| 20 | 4,427,218 | Statistical estimations in pharmacokinetics. | J Pharmacokinet Biopharm | 1974 | https://conductscience.org/library/papers/4427218 | PubMed |
| 21 | 13,974,496 | Antituberculosis drugs. | Pharmacol Rev | 1963 | https://conductscience.org/library/papers/13974496 | PubMed |
| 22 | 5,014,307 | Pharmacokinetics of three sulfonamides in the rabbit. | J Pharm Sci | 1972 | https://conductscience.org/library/papers/5014307 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,771,565 | The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39771565 | PubMed |
| 38,658,473 | Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics Modeling. | AAPS J | 2024 | https://conductscience.org/library/papers/38658473 | PubMed |
| 36,069,614 | Effects of Enzyme Induction and Polymorphism on the Pharmacokinetics of Isoniazid and Rifampin in Tuberculosis/HIV Patients. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/36069614 | PubMed |
| 35,928,262 | Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35928262 | PubMed |
| 34,518,943 | PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid. | Pharm Res | 2021 | https://conductscience.org/library/papers/34518943 | PubMed |
| 26,282,412 | Population pharmacokinetic analysis of isoniazid, acetylisoniazid, and isonicotinic acid in healthy volunteers. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26282412 | PubMed |
| 7,884,651 | Identifiability and indistinguishability of nonlinear pharmacokinetic models. | J Pharmacokinet Biopharm | 1994 | https://conductscience.org/library/papers/7884651 | PubMed |
| 7,448,108 | An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7448108 | PubMed |
| 7,310,645 | Metabolite pharmacokinetics: the area under the curve of metabolite and the fractional rate of metabolism of a drug after different routes of administration for renally and hepatically cleared drugs and metabolites. | J Pharmacokinet Biopharm | 1981 | https://conductscience.org/library/papers/7310645 | PubMed |
| 4,452,938 | The influence of bacterial gut hydrolysis on the fate of orally administered isonicotinuric acid in man. | J Pharmacokinet Biopharm | 1974 | https://conductscience.org/library/papers/4452938 | PubMed |
| 3,914,545 | A review of metabolite kinetics. | J Pharmacokinet Biopharm | 1985 | https://conductscience.org/library/papers/3914545 | PubMed |
| 2,677,314 | The problem of model indistinguishability in pharmacokinetics. | J Pharmacokinet Biopharm | 1989 | https://conductscience.org/library/papers/2677314 | PubMed |
| 1,206,480 | Plasma and salivary concentrations of isoniazid in man: preliminary findings in two slow acetylator subjects. | J Pharmacokinet Biopharm | 1975 | https://conductscience.org/library/papers/1206480 | PubMed |
| 480,149 | Sequential first-pass elimination of a metabolite derived from a precursor. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/480149 | PubMed |
| 391,461 | Clinical pharmacokinetics of isoniazid. | Clin Pharmacokinet | 1979 | https://conductscience.org/library/papers/391461 | PubMed |
| 328,206 | Disease and acetylation polymorphism. | Clin Pharmacokinet | 1977 | https://conductscience.org/library/papers/328206 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/978394
GET https://conductscience.org/api/papers/v1/978394/references?page=2